Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Prevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barré syndrome in Korea: a nationwide multicenter study.

Kim JK, Bae JS, Kim DS, Kusunoki S, Kim JE, Kim JS, Park YE, Park KJ, Song HS, Kim SY, Lim JG, Kim NH, Suh BC, Nam TS, Park MS, Choi YC, Sohn EH, Na SJ, Huh SY, Kwon O, Lee SY, Lee SH, Oh SY, Jeong SH, Lee TK, Kim DU.

J Clin Neurol. 2014 Apr;10(2):94-100. doi: 10.3988/jcn.2014.10.2.94.

2.

Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.

Press R, Matá S, Lolli F, Zhu J, Andersson T, Link H.

J Neurol Sci. 2001 Sep 15;190(1-2):41-7.

PMID:
11574105
3.

Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.

Créange A, Shahrizaila N, Salhi H, Lefaucheur JP, Yuki N.

J Peripher Nerv Syst. 2014 Jun;19(2):115-20. doi: 10.1111/jns5.12060.

PMID:
24750296
4.

[Antiganglioside autoantibody profiles in Guillain-Barré syndrome].

Caudie C, Vial C, Bancel J, Petiot P, Antoine JC, Gonnaud PM.

Ann Biol Clin (Paris). 2002 Sep-Oct;60(5):589-97. French.

5.

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.

Ho TW, Willison HJ, Nachamkin I, Li CY, Veitch J, Ung H, Wang GR, Liu RC, Cornblath DR, Asbury AK, Griffin JW, McKhann GM.

Ann Neurol. 1999 Feb;45(2):168-73.

PMID:
9989618
6.
7.

Patterns of Guillain-Barre syndrome in children: results from a Mexican population.

Nachamkin I, Arzarte Barbosa P, Ung H, Lobato C, Gonzalez Rivera A, Rodriguez P, Garcia Briseno A, Cordero LM, Garcia Perea L, Perez JC, Ribera M, Aldama PC, Guitérrez GD, Sarnat LF, García MR, Veitch J, Fitzgerald C, Cornblath DR, Rodriguez Pinto M, Griffin JW, Willison HJ, Asbury AK, McKhann GM.

Neurology. 2007 Oct 23;69(17):1665-71. Erratum in: Neurology. 2009 Mar 24;72(12):1110. Barbosa, P Arzate [corrected to Arzarte Barbosa, P]; Ung, H [corrected to Ung, Huong]; Rivera, A Gonzalez [corrected to Gonzalez Rivera, A]; Briseno, A Garcia [corrected to Garcia Briseno, A]; Perea, L Garcia [corrected to Garcia Perea, L]; Aldama, P Chico [added]; Gutiérrez, G Dávila [added]; Sarnat, L Flores [added]; García, Ruiz [added]; Cornblath, D [corrected to Cornblath, D R]; Pinto, M Rodriguez [corrected to Rodriguez Pinto, M].

PMID:
17898327
8.

Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study.

Sekiguchi Y, Uncini A, Yuki N, Misawa S, Notturno F, Nasu S, Kanai K, Noto Y, Fujimaki Y, Shibuya K, Ohmori S, Sato Y, Kuwabara S.

J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):23-8. doi: 10.1136/jnnp-2011-300309.

PMID:
22010183
9.

Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients.

Fan C, Jin H, Hao H, Gao F, Sun Y, Lu Y, Liu Y, Lv P, Cui W, Teng Y, Huang Y.

Muscle Nerve. 2016 Jul 27. doi: 10.1002/mus.25266. [Epub ahead of print]

PMID:
27464289
10.

Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.

Kannan MA, Ch RK, Jabeen SA, Mridula KR, Rao P, Borgohain R.

Neurol India. 2011 Sep-Oct;59(5):727-32. doi: 10.4103/0028-3886.86549.

11.

IgG antiganglioside antibodies in Guillain-Barré syndrome with bulbar palsy.

Yoshino H, Harukawa H, Asano A.

J Neuroimmunol. 2000 Jun 26;105(2):195-201.

PMID:
10742563
12.

GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.

Kaida K, Sonoo M, Ogawa G, Kamakura K, Ueda-Sada M, Arita M, Motoyoshi K, Kusunoki S.

Neurology. 2008 Nov 18;71(21):1683-90. doi: 10.1212/01.wnl.0000335160.72184.7d.

PMID:
19015484
13.

Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.

Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N.

Ann Neurol. 2000 Oct;48(4):624-31.

PMID:
11026446
14.

Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.

Kanzaki M, Kaida K, Ueda M, Morita D, Hirakawa M, Motoyoshi K, Kamakura K, Kusunoki S.

J Neurol Neurosurg Psychiatry. 2008 Oct;79(10):1148-52. doi: 10.1136/jnnp.2007.142950.

PMID:
18339728
15.

Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.

Schessl J, Koga M, Funakoshi K, Kirschner J, Muellges W, Weishaupt A, Gold R, Korinthenberg R.

Arch Dis Child. 2007 Jan;92(1):48-52.

16.

[Immune-mediated neuropathy].

Kusunoki S.

Rinsho Shinkeigaku. 2008 Nov;48(11):1023-5. Review. Japanese.

PMID:
19198151
17.

An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.

Ogawa G, Kaida K, Kuwahara M, Kimura F, Kamakura K, Kusunoki S.

J Neuroimmunol. 2013 Jan 15;254(1-2):141-5. doi: 10.1016/j.jneuroim.2012.09.005.

PMID:
23000056
18.

Anti-GT1a IgG in Guillain-Barré syndrome.

Koga M, Yoshino H, Morimatsu M, Yuki N.

J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):767-71.

19.

Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.

Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I.

Brain. 2000 Jan;123 ( Pt 1):116-24.

Items per page

Supplemental Content

Support Center